differentiated thyroid cancer

You have access
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study
Lin Cheng, Ri Sa, Qiong Luo, Hao Fu, Yuchen Jin, Linglin Tang, Yi Yang, Chunjing Yu and Libo Chen

Journal of Nuclear Medicine January 1, 2021, 62 (1) 62-68; DOI: https://doi.org/10.2967/jnumed.120.243642
You have access
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After ¹³¹I Therapy for Thyroid Cancer
Di Wu, Cristiane J. Gomes Lima, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand

Journal of Nuclear Medicine March 1, 2020, 61 (3) 397-404; DOI: https://doi.org/10.2967/jnumed.119.230730
You have access
Detection at Public Facilities of ¹³¹I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients
Athanasios Bikas, Di Wu, Evelyn Bethancourt, Michael Orquiza, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand

Journal of Nuclear Medicine May 1, 2019, 60 (5) 638-643; DOI: https://doi.org/10.2967/jnumed.118.213256
You have access
Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in ¹²⁴I PET/CT–Based Dosimetry for ¹³¹I Therapy of Metastatic Differentiated Thyroid Cancer
Donika Plyku, Robert F. Hobbs, Kevin Huang, Frank Atkins, Carlos Garcia, George Sgouros and Douglas Van Nostrand

Journal of Nuclear Medicine July 1, 2017, 58 (7) 1146-1154; DOI: https://doi.org/10.2967/jnumed.116.179366
You have access
Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study
Esther N. Klein Hesselink, Adrienne H. Brouwers, Johan R. de Jong, Anouk N.A. van der Horst-Schrivers, Rob P. Coppes, Joop D. Lefrandt, Piet L. Jager, Arjan Vissink and Thera P. Links

Journal of Nuclear Medicine November 1, 2016, 57 (11) 1685-1691; DOI: https://doi.org/10.2967/jnumed.115.169888
You have access
¹²⁴I PET/CT to Predict the Outcome of Blind ¹³¹I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)
Jakob W. Kist, Bart de Keizer, Manfred van der Vlies, Adrienne H. Brouwers, Dyde A. Huysmans, Friso M. van der Zant, Rick Hermsen, Marcel P.M. Stokkel, Otto S. Hoekstra and Wouter V. Vogel; for the THYROPET Study Group

Journal of Nuclear Medicine May 1, 2016, 57 (5) 701-707; DOI: https://doi.org/10.2967/jnumed.115.168138
You have access
DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy
Uta Eberlein, Harry Scherthan, Christina Bluemel, Michel Peper, Constantin Lapa, Andreas Konrad Buck, Matthias Port and Michael Lassmann

Journal of Nuclear Medicine February 1, 2016, 57 (2) 173-179; DOI: https://doi.org/10.2967/jnumed.115.164814
You have access
Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy
Tobias Markus Maier, Otmar Schober, Joachim Gerß, Dennis Görlich, Christian Wenning, Michael Schaefers, Burkhard Riemann and Alexis Vrachimis

Journal of Nuclear Medicine February 1, 2015, 56 (2) 190-195; DOI: https://doi.org/10.2967/jnumed.114.150284
You have access
Clinical Utility of ¹⁸F-FDG PET/CT Concurrent with ¹³¹I Therapy in Intermediate–to–High-Risk Patients with Differentiated Thyroid Cancer: Dual-Center Experience with 286 Patients
Jeong Won Lee, Sang Mi Lee, Dae Ho Lee and Yeo Joo Kim

Journal of Nuclear Medicine August 1, 2013, 54 (8) 1230-1236; DOI: https://doi.org/10.2967/jnumed.112.117119
You have access
Integrin α_vβ₃ Imaging of Radioactive Iodine–Refractory Thyroid Cancer Using ^99mTc-3PRGD2
Dan Zhao, Xiaona Jin, Fang Li, Jun Liang and Yansong Lin

Journal of Nuclear Medicine December 1, 2012, 53 (12) 1872-1877; DOI: https://doi.org/10.2967/jnumed.112.107821

Main menu

User menu

Search

differentiated thyroid cancer